Gargi Patel

1.5k total citations · 2 hit papers
39 papers, 981 citations indexed

About

Gargi Patel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Gargi Patel has authored 39 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Gargi Patel's work include HER2/EGFR in Cancer Research (9 papers), Advanced Breast Cancer Therapies (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Gargi Patel is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Advanced Breast Cancer Therapies (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Gargi Patel collaborates with scholars based in United Kingdom, United States and Australia. Gargi Patel's co-authors include Tony Ng, Christos S. Karapetis, Scott E. Woodman, Timothy Price, Gilbert O. Fruhwirth, Rajiv Kumar, Giuseppe Curigliano, Carlos H. Barrios, Aditya Bardia and Yosef Yarden and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Gargi Patel

38 papers receiving 967 citations

Hit Papers

Trastuzumab Deruxtecan after Endocrine Therapy in Metasta... 2024 2026 2025 2024 2024 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
    2024 144 citations Aditya Bardia, Xichun Hu et al. New England Journal of Medicine profile →
  2. Trastuzumab deruxtecan (T-DXd) vs physician’s choice of chemotherapy (TPC) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2 (HER2)-low or HER2-ultralow metastatic breast cancer (mBC) with prior endocrine therapy (ET): Primary results from DESTINY-Breast06 (DB-06).
    2024 52 citations Giuseppe Curigliano, Xichun Hu et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gargi Patel United Kingdom 21 502 324 282 191 111 39 981
Mohammad Tabrizi United States 14 354 0.7× 202 0.6× 554 2.0× 460 2.4× 111 1.0× 26 1.3k
Georgia M. Beasley United States 24 1.3k 2.5× 185 0.6× 706 2.5× 51 0.3× 157 1.4× 121 1.8k
Michael Hoeckel Germany 13 220 0.4× 225 0.7× 349 1.2× 288 1.5× 608 5.5× 17 1.2k
Simon J. Hollingsworth United Kingdom 16 351 0.7× 153 0.5× 350 1.2× 61 0.3× 224 2.0× 56 951
Fangmeng Fu China 15 211 0.4× 130 0.4× 293 1.0× 77 0.4× 286 2.6× 66 744
Suzanne E. Davis United States 9 1.5k 3.0× 401 1.2× 447 1.6× 94 0.5× 92 0.8× 13 2.2k
Keith D. Amos United States 17 1.1k 2.2× 127 0.4× 494 1.8× 188 1.0× 575 5.2× 32 1.9k
Eugenia Girda United States 13 306 0.6× 167 0.5× 215 0.8× 36 0.2× 179 1.6× 55 769
Christian Rudlowski Germany 23 478 1.0× 128 0.4× 527 1.9× 115 0.6× 422 3.8× 61 1.6k

Countries citing papers authored by Gargi Patel

Since Specialization
Citations

This map shows the geographic impact of Gargi Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gargi Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gargi Patel more than expected).

Fields of papers citing papers by Gargi Patel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gargi Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gargi Patel. The network helps show where Gargi Patel may publish in the future.

Co-authorship network of co-authors of Gargi Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Gargi Patel. A scholar is included among the top collaborators of Gargi Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gargi Patel. Gargi Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Curigliano, Giuseppe, Xichun Hu, Rebecca Dent, et al.. (2024). Trastuzumab deruxtecan (T-DXd) vs physician’s choice of chemotherapy (TPC) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2 (HER2)-low or HER2-ultralow metastatic breast cancer (mBC) with prior endocrine therapy (ET): Primary results from DESTINY-Breast06 (DB-06).. Journal of Clinical Oncology. 42(17_suppl). LBA1000–LBA1000. 52 indexed citations breakdown →
2.
Bardia, Aditya, Xichun Hu, Rebecca Dent, et al.. (2024). Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer. New England Journal of Medicine. 391(22). 2110–2122. 144 indexed citations breakdown →
3.
Patel, Gargi, et al.. (2023). A Rare Case of Presence of Persistent Mullerian Duct Syndrome in Mixed Non Seminomatous Germ Cell Tumour of Testis. International Journal of Science and Research (IJSR). 12(12). 1459–1462. 1 indexed citations
4.
Patel, Gargi, et al.. (2023). An Unusual Eyelid Mass of Cysticercosis. International Journal of Science and Research (IJSR). 12(11). 321–323. 1 indexed citations
5.
Patel, Harshil, et al.. (2023). Knowledge and Attitude Toward Organ Donation Among Interns and Residents in a Tertiary Care Hospital in Gujarat, India. Cureus. 15(8). e43797–e43797. 6 indexed citations
6.
Azad, Priti, et al.. (2021). Protective role of estrogen against excessive erythrocytosis in Monge’s disease. Experimental & Molecular Medicine. 53(1). 125–135. 28 indexed citations
7.
8.
Yu, Helena A., Sarah B. Goldberg, Xiuning Le, et al.. (2019). P2.01-22 ORCHARD: A Phase II Platform Study in Patients with Advanced NSCLC Who Have Progressed on First-Line Osimertinib Therapy. Journal of Thoracic Oncology. 14(10). S647–S647. 22 indexed citations
9.
Claus, Jeroen, Gargi Patel, Flavia Autore, et al.. (2018). Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface. eLife. 7. 51 indexed citations
10.
Sharma, Padmanee, Luc Dirix, Filip De Vos, et al.. (2018). Efficacy and tolerability of tremelimumab in patients with metastatic pancreatic ductal adenocarcinoma.. Journal of Clinical Oncology. 36(4_suppl). 470–470. 20 indexed citations
11.
Weitsman, Gregory, Paul R. Barber, Lan K. Nguyen, et al.. (2016). HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status. Oncotarget. 7(32). 51012–51026. 25 indexed citations
12.
Kumar, Rajiv, Gargi Patel, Ganessan Kichenadasse, et al.. (2015). Delayed onset of benign pleural effusion following concurrent chemoradiotherapy for inoperable non‐small‐cell lung cancer. Internal Medicine Journal. 45(2). 218–221. 2 indexed citations
13.
Kumar, Rajiv, Timothy Price, Carol Beeke, et al.. (2013). Colorectal Cancer Survival: An Analysis of Patients With Metastatic Disease Synchronous and Metachronous With the Primary Tumor. Clinical Colorectal Cancer. 13(2). 87–93. 55 indexed citations
14.
15.
Patel, Gargi, Katherine Lawler, Gregory Weitsman, et al.. (2011). COMBINING PROTEIN INTERACTION AND GENE PROFILING METHODS FOR PREDICTING LAPATINIB RESPONSE. Annals of Oncology. 22. 43–43. 6 indexed citations
16.
Woodman, Scott E. & Gargi Patel. (2011). Profile of ipilimumab and its role in the treatment of metastatic melanoma. Drug Design Development and Therapy. 5. 489–489. 33 indexed citations
17.
El‐Hattab, Ayman W., Ping Fang, Weihong Jin, et al.. (2011). Int22h-1/int22h-2-mediated Xq28 rearrangements: intellectual disability associated with duplications and in utero male lethality with deletions. Journal of Medical Genetics. 48(12). 840–850. 40 indexed citations
18.
Jiao, Yan, Katherine Lawler, Gargi Patel, et al.. (2011). DART: Denoising Algorithm based on Relevance network Topology improves molecular pathway activity inference. BMC Bioinformatics. 12(1). 403–403. 23 indexed citations
19.
Kelleher, Muireann, Gilbert O. Fruhwirth, Gargi Patel, et al.. (2009). The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients. Targeted Oncology. 4(3). 235–252. 41 indexed citations
20.
Simon, Tony J., Scott Peterson, Gargi Patel, & K. Sathian. (1998). Do the magnocellular and parvocellular visual pathways contribute differentially to subitizing and counting?. Perception & Psychophysics. 60(3). 451–464. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammad Tabrizi Breakdown of academic impact, for papers by Georgia M. Beasley Breakdown of academic impact, for papers by Michael Hoeckel Breakdown of academic impact, for papers by Simon J. Hollingsworth Breakdown of academic impact, for papers by Fangmeng Fu Breakdown of academic impact, for papers by Suzanne E. Davis Breakdown of academic impact, for papers by Keith D. Amos Breakdown of academic impact, for papers by Eugenia Girda Breakdown of academic impact, for papers by Christian Rudlowski
Rankless by CCL
2026